These outcomes, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 help the idea of targeting ACKR3 as a unique method to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated Conditions. As well as the described https://emilyw035qsk8.vblogetin.com/profile